News Conference News AHA 2018 Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT Michael O'Riordan November 10, 2018
News Opinion Fellow Talk A Look Back at TCT 2018: What I Took Away From the Meeting Yashasvi Chugh, MD October 23, 2018
News Opinion Editor's Corner TCT 2018 My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse Shelley Wood October 12, 2018
News Conference News TCT 2018 Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos Michael O'Riordan October 02, 2018
News Daily News Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51 Michael O'Riordan July 06, 2018
News Daily News Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated L.A. McKeown May 15, 2018
News Features ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging Michael O'Riordan March 23, 2018